Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Windtree Therapeutics Inc /de/ (WINT) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Windtree Therapeutics Inc /de/. Table 2 shows the detailed insider transactions. This company's CIK number is 946486.
Total stock buying since 2005: $28,815,532.
Total stock sales since 2005: $2,024,618.
Total stock option exercises since 2005: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 5,431 | $4,942 | 0 | $0 | 0 | $0 |
| 2023 | 7,812 | $9,934 | 0 | $0 | 0 | $0 |
| 2022 | 29,500 | $17,717 | 0 | $0 | 0 | $0 |
| 2021 | 1,456,239 | $2,470,498 | 1,239,088 | $1,982,540 | 0 | $0 |
| 2020 | 421,828 | $3,041,897 | 0 | $0 | 0 | $0 |
| 2019 | 4,987,329 | $15,081,243 | 0 | $0 | 0 | $0 |
| 2018 | 541,667 | $2,600,001 | 0 | $0 | 0 | $0 |
| 2016 | 7,500 | $15,382 | 0 | $0 | 0 | $0 |
| 2015 | 133,334 | $0 | 0 | $0 | 0 | $0 |
| 2013 | 3,000 | $8,640 | 0 | $0 | 0 | $0 |
| 2010 | 0 | $0 | 17,000 | $3,604 | 0 | $0 |
| 2008 | 388,289 | $470,985 | 0 | $0 | 0 | $0 |
| 2007 | 283,511 | $622,293 | 0 | $0 | 0 | $0 |
| 2005 | 650,000 | $4,472,000 | 5,783 | $38,474 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-10 | 5,431 | $4,942 | 0 | $0 | 0 | $0 |
| 2023-09 | 5,000 | $4,800 | 0 | $0 | 0 | $0 |
| 2023-04 | 2,812 | $5,134 | 0 | $0 | 0 | $0 |
| 2022-07 | 8,000 | $2,986 | 0 | $0 | 0 | $0 |
| 2022-06 | 11,500 | $4,831 | 0 | $0 | 0 | $0 |
| 2022-03 | 10,000 | $9,900 | 0 | $0 | 0 | $0 |
| 2021-12 | 1,239,088 | $1,982,540 | 1,239,088 | $1,982,540 | 0 | $0 |
| 2021-11 | 1,860 | $2,985 | 0 | $0 | 0 | $0 |
| 2021-10 | 56,000 | $106,580 | 0 | $0 | 0 | $0 |
| 2021-04 | 5,791 | $13,483 | 0 | $0 | 0 | $0 |
| 2021-03 | 153,500 | $364,910 | 0 | $0 | 0 | $0 |
| 2020-10 | 3,250 | $18,959 | 0 | $0 | 0 | $0 |
| 2020-06 | 12,400 | $90,812 | 0 | $0 | 0 | $0 |
| 2020-05 | 402,120 | $2,915,367 | 0 | $0 | 0 | $0 |
| 2020-02 | 2,000 | $8,150 | 0 | $0 | 0 | $0 |
| 2020-01 | 2,058 | $8,609 | 0 | $0 | 0 | $0 |
| 2019-12 | 4,987,329 | $15,081,243 | 0 | $0 | 0 | $0 |
| 2018-04 | 541,667 | $2,600,001 | 0 | $0 | 0 | $0 |
| 2016-10 | 7,500 | $15,382 | 0 | $0 | 0 | $0 |
| 2015-07 | 133,334 | $0 | 0 | $0 | 0 | $0 |
| 2013-02 | 3,000 | $8,640 | 0 | $0 | 0 | $0 |
| 2010-12 | 0 | $0 | 17,000 | $3,604 | 0 | $0 |
| 2008-11 | 195,000 | $195,517 | 0 | $0 | 0 | $0 |
| 2008-10 | 83,289 | $92,603 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-10-08 | Fraser Craig (President and CEO) | Buy | 5,431 | .91 | 4,942 |
| 2023-09-27 | Fraser Craig (President and CEO) | Buy | 2,500 | 1.02 | 2,550 |
| 2023-09-26 | Fraser Craig (President and CEO) | Buy | 2,500 | .90 | 2,250 |
| 2023-04-26 | Fraser Craig (President and CEO) | Buy | 1,497 | 1.77 | 2,649 |
| 2023-04-25 | Fraser Craig (President and CEO) | Buy | 1,315 | 1.89 | 2,485 |
| 2022-07-27 | Fraser Craig (President and CEO) | Buy | 2,500 | .38 | 950 |
| 2022-07-26 | Hamill John P. (SVP & CFO) | Buy | 3,000 | .37 | 1,101 |
| 2022-07-26 | Fraser Craig (President and CEO) | Buy | 2,500 | .37 | 935 |
| 2022-06-30 | Fraser Craig (President and CEO) | Buy | 4,500 | .43 | 1,926 |
| 2022-06-29 | Fraser Craig (President and CEO) | Buy | 7,000 | .41 | 2,905 |
| 2022-03-16 | Fraser Craig (President and CEO) | Buy | 2,000 | .98 | 1,960 |
| 2022-03-15 | Simonson Steven (SVP, Chief Medical Officer) | Buy | 5,000 | 1.00 | 5,000 |
| 2022-03-15 | Fraser Craig (President and CEO) | Buy | 3,000 | .98 | 2,940 |
| 2021-12-30 | Center Laboratories, Inc. | Buy | 1,239,088 | 1.60 | 1,982,540 |
| 2021-12-30 | Bioengine Capital Inc. | Sale | 1,239,088 | 1.60 | 1,982,540 |
| 2021-11-19 | Fraser Craig (President and CEO) | Buy | 930 | 1.60 | 1,488 |
| 2021-11-18 | Fraser Craig (President and CEO) | Buy | 930 | 1.61 | 1,497 |
| 2021-10-22 | Fraser Craig (President and CEO) | Buy | 3,000 | 1.90 | 5,700 |
| 2021-10-19 | Huang James (Director) | Buy | 50,000 | 1.90 | 95,150 |
| 2021-10-19 | Fraser Craig (President and CEO) | Buy | 3,000 | 1.91 | 5,730 |
| 2021-04-16 | Hamill John P. (SVP & CFO) | Buy | 1,000 | 2.07 | 2,067 |
| 2021-04-16 | Fraser Craig (President and CEO) | Buy | 1,000 | 2.09 | 2,092 |
| 2021-04-15 | Fraser Craig (President and CEO) | Buy | 1,000 | 2.24 | 2,240 |
| 2021-04-07 | Curtis Eric (SVP & COO) | Buy | 791 | 2.52 | 1,990 |
| 2021-04-06 | Fraser Craig (President and CEO) | Buy | 500 | 2.57 | 1,285 |
| 2021-04-05 | Fraser Craig (President and CEO) | Buy | 1,000 | 2.58 | 2,580 |
| 2021-04-01 | Fraser Craig (President and CEO) | Buy | 500 | 2.46 | 1,229 |
| 2021-03-31 | Huang James (Director) | Buy | 150,000 | 2.36 | 354,000 |
| 2021-03-31 | Fraser Craig (President and CEO) | Buy | 500 | 2.32 | 1,160 |
| 2021-03-25 | Hamill John P. (SVP & CFO) | Buy | 1,500 | 3.25 | 4,875 |
| 2021-03-25 | Simonson Steven (SVP, Chief Medical Officer) | Buy | 1,500 | 3.25 | 4,875 |
| 2020-10-28 | Fraser Craig (President and CEO) | Buy | 250 | 6.56 | 1,640 |
| 2020-10-23 | Huang James (Director) | Buy | 1,000 | 6.67 | 6,666 |
| 2020-10-09 | Fraser Craig (President and CEO) | Buy | 250 | 5.83 | 1,456 |
| 2020-10-08 | Curtis Eric (SVP & COO) | Buy | 500 | 5.27 | 2,635 |
| 2020-10-07 | Hamill John P. (SVP & CFO) | Buy | 1,000 | 5.27 | 5,270 |
| 2020-10-07 | Fraser Craig (President and CEO) | Buy | 250 | 5.17 | 1,292 |
| 2020-06-04 | Huang James (Director) | Buy | 12,200 | 7.32 | 89,328 |
| 2020-06-03 | Huang James (Director) | Buy | 200 | 7.42 | 1,484 |
| 2020-05-22 | Schreiber Brian D (Director) | Buy | 2,069 | 7.25 | 15,000 |
| 2020-05-22 | Simonson Steven (SVP, Chief Medical Officer) | Buy | 517 | 7.25 | 3,748 |
| 2020-05-22 | Huang James (Director) | Buy | 275,862 | 7.25 | 1,999,999 |
| 2020-05-22 | Fraser Craig (President and CEO) | Buy | 2,069 | 7.25 | 15,000 |
| 2020-05-22 | Templeton Mary B Esq (SVP, Gen Counsel & Corp Sec) | Buy | 1,103 | 7.25 | 7,996 |
| 2020-05-22 | Tattory John A (SVP & CFO) | Buy | 449 | 7.25 | 3,255 |
| 2020-05-22 | Geffken Daniel E. (Director) | Buy | 2,069 | 7.25 | 15,000 |
| 2020-05-22 | Leone John R (Director) | Buy | 2,069 | 7.25 | 15,000 |
| 2020-05-22 | Peacock Bruce (Director) | Buy | 3,500 | 7.25 | 25,375 |
| 2020-05-22 | Joseph Mahady M (Director) | Buy | 2,069 | 7.25 | 15,000 |
| 2020-05-20 | Center Laboratories, Inc. | Buy | 55,172 | 7.25 | 399,997 |
| 2020-05-20 | Bioengine Capital Inc. | Buy | 55,172 | 7.25 | 399,997 |
| 2020-02-18 | Huang James (Director) | Buy | 400 | 3.84 | 1,535 |
| 2020-02-11 | Fraser Craig (President and CEO) | Buy | 250 | 4.10 | 1,025 |
| 2020-02-10 | Fraser Craig (President and CEO) | Buy | 250 | 4.10 | 1,025 |
| 2020-02-07 | Huang James (Director) | Buy | 500 | 4.05 | 2,025 |
| 2020-02-04 | Fraser Craig (President and CEO) | Buy | 500 | 4.24 | 2,120 |
| 2020-02-03 | Fraser Craig (President and CEO) | Buy | 100 | 4.20 | 420 |
| 2020-01-17 | Huang James (Director) | Buy | 2,000 | 4.18 | 8,366 |
| 2020-01-16 | Huang James (Director) | Buy | 58 | 4.20 | 243 |
| 2019-12-31 | Huang James (Director) | Buy | 15,442 | 4.05 | 62,524 |
| 2019-12-30 | Huang James (Director) | Buy | 909 | 3.81 | 3,463 |
| 2019-12-27 | Huang James (Director) | Buy | 4,091 | 3.73 | 15,259 |
| 2019-12-06 | Lph Ii Investments Ltd | Buy | 1,655,629 | 3.02 | 4,999,999 |
| 2019-12-06 | Lee's Pharmaceutical Holdings Ltd | Buy | 1,655,629 | 3.02 | 4,999,999 |
| 2019-12-06 | Huang James (Director) | Buy | 1,655,629 | 3.02 | 4,999,999 |
| 2018-04-04 | Lee's Pharmaceutical Holdings Ltd | Buy | 541,667 | 4.80 | 2,600,001 |
| 2016-10-28 | Fraser Craig (President and CEO) | Buy | 7,500 | 2.05 | 15,382 |
| 2015-07-22 | Simonson Steven (SVP, Chief Development Officer) | Buy | 16,667 | .00 | 0 |
| 2015-07-22 | Templeton Mary B Esq (SVP, Gen Counsel & Corp Sec) | Buy | 16,667 | .00 | 0 |
| 2015-07-22 | Tattory John A (SVP & Chief Financial Officer) | Buy | 8,333 | .00 | 0 |
| 2015-07-22 | Leone John R | Buy | 50,000 | .00 | 0 |
| 2015-07-22 | Cooper John G (President & CEO) | Buy | 41,667 | .00 | 0 |
| 2013-02-19 | Leone John R | Buy | 3,000 | 2.88 | 8,640 |
| 2010-12-17 | Lopez David L (Executive VP & Legal Counsel) | Sale | 17,000 | .21 | 3,604 |
| 2008-11-20 | Rosenthale Marvin E (Director) | Buy | 15,174 | .90 | 13,656 |
| 2008-11-19 | Rosenthale Marvin E (Director) | Buy | 33,055 | .93 | 30,741 |
| 2008-11-18 | Rosenthale Marvin E (Director) | Buy | 26,771 | 1.00 | 26,771 |
| 2008-11-17 | Capetola Robert J (President/CEO) | Buy | 50,000 | 1.03 | 50,850 |
| 2008-11-14 | Capetola Robert J (President/CEO) | Buy | 10,000 | 1.12 | 11,200 |
| 2008-11-13 | Lopez David L (Executive VP & Legal Counsel) | Buy | 5,000 | 1.03 | 5,150 |
| 2008-11-13 | Capetola Robert J (President/CEO) | Buy | 10,000 | 1.01 | 10,149 |
| 2008-11-11 | Lopez David L (Executive VP & Legal Counsel) | Buy | 5,000 | 1.32 | 6,600 |
| 2008-10-17 | Lopez David L (Executive VP & Legal Counsel) | Buy | 12,000 | 1.65 | 19,800 |
| 2008-10-08 | Rosenthale Marvin E (Director) | Buy | 10,000 | .80 | 8,000 |
| 2008-10-03 | Rosenthale Marvin E (Director) | Buy | 51,289 | .90 | 45,903 |
| 2008-10-01 | Katzer Charles F (SVP, Manufacturing Operations) | Buy | 10,000 | 1.89 | 18,900 |
| 2008-09-30 | Capetola Robert J (President/CEO) | Buy | 75,000 | 1.87 | 140,550 |
| 2008-09-29 | Rosenthale Marvin E (Director) | Buy | 15,000 | .94 | 14,025 |
| 2008-08-18 | Amick W Thomas (Director) | Buy | 10,000 | 1.93 | 19,300 |
| 2008-05-12 | Rosenthale Marvin E (Director) | Buy | 10,000 | .90 | 8,990 |
| 2007-11-20 | Rosenthale Marvin E (Director) | Buy | 15,000 | 2.40 | 36,000 |
| 2007-11-19 | Lopez David L (Executive VP & Legal Counsel) | Buy | 7,900 | 2.43 | 19,220 |
| 2007-11-16 | Capetola Robert J (President/CEO) | Buy | 50,000 | 2.54 | 127,000 |
| 2007-11-15 | Amick W Thomas (Director) | Buy | 10,000 | 2.32 | 23,200 |
| 2007-08-03 | Capetola Robert J (President/CEO) | Buy | 25,000 | 2.15 | 53,625 |
| 2007-03-19 | Rosenthale Marvin E (Director) | Buy | 500 | 2.04 | 1,020 |
| 2007-03-15 | Rosenthale Marvin E (Director) | Buy | 4,611 | 2.04 | 9,406 |
| 2007-03-14 | Rosenthale Marvin E (Director) | Buy | 16,000 | 2.06 | 33,099 |
| 2007-03-13 | Rosenthale Marvin E (Director) | Buy | 10,000 | 2.05 | 20,500 |
| 2007-03-09 | Amick W Thomas (Director) | Buy | 10,000 | 2.12 | 21,170 |
| 2007-03-09 | Link Max (Director) | Buy | 40,000 | 2.09 | 83,760 |
| 2007-03-06 | Lopez David L (Executive VP & Legal Counsel) | Buy | 10,000 | 2.03 | 20,290 |
| 2007-03-05 | Katzer Charles F (SVP, Manufacturing Operations) | Buy | 10,000 | 1.99 | 19,850 |
| 2007-03-05 | Rosenthale Marvin E (Director) | Buy | 5,500 | 1.95 | 10,730 |
| 2007-03-02 | Miller Thomas F (SVP, Commercial..& Corp. Dev.) | Buy | 5,000 | 2.04 | 10,180 |
| 2007-03-02 | Cooper John G (EXEC. VP, CFO) | Buy | 18,000 | 2.09 | 37,620 |
| 2007-03-02 | Rosenthale Marvin E (Director) | Buy | 10,200 | 2.07 | 21,083 |
| 2007-03-02 | Capetola Robert J (President/CEO) | Buy | 25,000 | 2.09 | 52,325 |
| 2007-03-01 | Rosenthale Marvin E (Director) | Buy | 4,800 | 2.07 | 9,916 |
| 2005-10-26 | Esteve Antonio Phd (Director) | Buy | 650,000 | 6.88 | 4,472,000 |
| 2005-05-23 | Niven Ralph (SVP- Preclinical Dev) | Sale | 5,783 | 6.65 | 38,474 |
Insider trading activities including stock purchases, stock sales, and option exercises of WINT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Windtree Therapeutics Inc /de/ (symbol WINT, CIK number 946486) see the Securities and Exchange Commission (SEC) website.